News from Asia

id-100259735

Mesoblast’s heart treatment MPCs patented in Japan

March 30, 2015  |   News

This patent provides commercial rights in Japan through to at least 29 March 2024, with potential for patent term extension for up to five years

id-100146305

Bayer receives approval for Gadovist injection in Japan

March 30, 2015  |   News

Gadovist is the first high concentration/high relaxivity gadolinium-based contrast agent to be approved in Japan

id-10088885

Chugai, Gilead get Japanese approval for additional indication of antiviral drug Copegus

March 30, 2015  |   News

Chugai claims that the combination therapy of Copegus and Sovaldi is the first all-oral treatment regimen for patients with serogroup 2 hepatitis C virus in Japan

More News from Asia

Survey Box

Medical Tourism

Will rise in medical tourism lead to more innovations in healthcare?

Send this article by email

X